Lund Hemodynamic Lab
1 – 20 of 76
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Letter
-
Mark
Left ventricular dysfunction in pulmonary arterial hypertension is attributed to underfilling rather than intrinsic myocardial disease : a CMR 2D phase contrast study
(
- Contribution to journal › Article
- 2023
-
Mark
Risk assessment in pulmonary arterial hypertension : A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
(
- Contribution to journal › Letter
-
Mark
Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension : A Swedish single-center study
(
- Contribution to journal › Article
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
(
- Contribution to journal › Article
-
Mark
Evaluation of the European Society of Cardiology/European Respiratory Society derived three-and four-strata risk stratification models in pulmonary arterial hypertension : Introducing an internet-based risk stratification calculator
(
- Contribution to journal › Article
-
Mark
Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
(
- Contribution to journal › Article
-
Mark
Extracellular Vesicle-Associated TWEAK Contributes to Vascular Inflammation and Remodeling During Acute Cellular Rejection
(
- Contribution to journal › Article
-
Mark
Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?
(
- Contribution to journal › Letter
-
Mark
Plasma tumour necrosis factor-alpha-related proteins in prognosis of heart failure with pulmonary hypertension
(
- Contribution to journal › Article
- 2022
-
Mark
Bone mineral density in pediatric heart transplanted patients: A retrospective single-centre study at Skåne University Hospital in Lund 1988-2016
(
- Contribution to journal › Article
-
Mark
Higher plasma IL-6 and PTX3 are associated with worse survival in left heart failure with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Impact of bridging with left ventricular assist device on right ventricular function following heart transplantation
(
- Contribution to journal › Article
-
Mark
The Authors' Reply to the Letter “Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis”
(
- Contribution to journal › Letter
-
Mark
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Bioactive adrenomedullin for assessment of venous congestion in heart failure
(
- Contribution to journal › Article
-
Mark
Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Association between central haemodynamics and renal function in advanced heart failure : a nationwide study from Sweden
(
- Contribution to journal › Article